Health Catalyst, Inc Common Stock (HCAT) is a publicly traded Healthcare sector company. As of November 5, 2026, HCAT trades at $1.49 with a market cap of $119.66M and a P/E ratio of -0.47. HCAT moved -6.60% today. Year to date, HCAT is -30.35%; over the trailing twelve months it is -47.36%. Its 52-week range spans $0.96 to $5.06. Analyst consensus is neutral with an average price target of $1.83. Rallies surfaces HCAT's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks the latest HCAT news, catalysts, market updates, source links, and AI summaries when news is available.
| Metric | Value |
|---|---|
| Price | $1.49 |
| Market Cap | $119.66M |
| P/E Ratio | -0.47 |
| EPS | $-3.69 |
| Dividend Yield | 0.00% |
| 52-Week High | $5.06 |
| 52-Week Low | $0.96 |
| Volume | 272.12K |
| Avg Volume | 0 |
| Revenue (TTM) | $292.25M |
| Net Income | $-264.82M |
| Gross Margin | 0.00% |
6 analysts cover HCAT: 0 strong buy, 1 buy, 5 hold, 0 sell, 0 strong sell. Consensus rating is neutral. Average price target: $1.83.